HCA has announced that Joseph A. Sowell III will become its senior vice president and chief development officer, effective Dec. 1, 2009, according to an HCA news release.
The Latest
TLC Vision Corp., which owns and operates 70 eye surgery centers throughout North America, experienced a net loss of $10.04 million in the third quarter of 2009 and a 10 percent drop in sales from the same time period in…
The U.S. market for anesthesia, respiratory and sleep management devices will reach $4.1 billion by 2015, according to a news release by iData Research, a leading global authority in medical device, dental and pharmaceutical market research.
Amkai was recently featured in a prestigious research report published by the Parsons Institute for Information Mapping, a research, development and services arm of the New School in New York, which named six electronic medical record software systems as having…
A coalition of medical specialty organizations, including the American Academy of Ophthalmology, congratulated the Center for Medicare and Medicaid Services for its careful and reasoned implementation of up-to-date practice expense rates into its physician payments, according to a joint news…
Editor's Note: This article by Paul Cadorette, director of education for mdStrategies, originally appeared in The Coding Advocate, mdStrategies free monthly newsletter. Sign-up to receive this newsletter by clicking here.
QSE Technologies, a premiere IT systems integrator serving the ambulatory healthcare, has been named one of the top 250 private companies in Colorado by ColoradoBiz for the fifth year in a row.
Kenneth Livesay, a former executive of Birmingham, Ala.-based HealthSouth Corp., should be sentenced to jail time for his role in a fraud scheme to "artificially inflate HealthSouth's earnings and to falsely report HealthSouth's financial condition," according to an opinion by…
Christ Hospital in Cincinnati has acquired Redbank Surgery Center, which is currently a joint venture between the hospital and local physicians, according to a report by the Business Courier of Cincinnati.
A recent study published in the November issue of Archives of Ophthalmology suggests that the drug naltrexone hydrochloride may reduce ocular complications caused by Type 1 diabetes, such as dry eye and loss of corneal sensation.